Syndecan-1 Is Required for Robust Growth, Vascularization, and Metastasis of Myeloma Tumors in Vivo
2009 · Journal of Biological Chemistry · 97 citations
https://doi.org/10.1074/jbc.m109.018473
Y
Yang Yang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
109
Papers
979
Citations
15
h-index
21
i10-index
Yang Yang is an academic researcher from Guilin Medical University. The author has contributed to research in topics: Multiple Myeloma Research and Treatments & Peptidase Inhibition and Analysis & Bone health and treatments. The author has an h-index of 15, co-authored 93 publications.
ORCID: 0000-0001-5171-6226Papers by this author
worksA Small Molecule Inhibitor, OGP46, Is Effective against Imatinib-Resistant BCR-ABL Mutations via the BCR-ABL/JAK-STAT Pathway
2020 · Molecular Therapy — Oncolytics · 16 citations
https://doi.org/10.1016/j.omto.2020.06.008
Thymic rebound hyperplasia post-chemotherapy mistaken as disease progression in a patient with lymphoma involving mediastinum: a case report and reflection
2021 · BMC Surgery · 13 citations
https://doi.org/10.1186/s12893-021-01048-y
Efficacy of Intermittent, Oral Famciclovir Prophylaxis for Bortezomib-Induced Herpes Zoster in Multiple Myeloma Patients
2022 · Frontiers in Oncology · 7 citations
https://doi.org/10.3389/fonc.2022.843032
Impact of AML1/ETO Fusion on the Efficacy of Venetoclax Plus Hypomethylating Agents in Newly Diagnosed Acute Myeloid Leukemia
2024 · Targeted Oncology · 5 citations
https://doi.org/10.1007/s11523-024-01039-y
Dialysis-Dependence is Associated with Poor Prognosis in Multiple Myeloma: a Multicenter Retrospective Cohort Study
2025 · Clinical Lymphoma Myeloma & Leukemia · 0 citations
https://doi.org/10.1016/s2152-2650(25)03625-0
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat